Keywords: Nycomed, Third quarter 2009 results, Pantoprazole, Daxas

Nycomed reports satisfactory 3rd-quarter 2009 performance, despite generic erosion of pantoprazole sales

Article | 13 November 2009

Privately-owned Swiss prescription and over-the-counter drugmaker Nycomed reports continued satisfactory performance in the third quarter 2009, with total net turnover increasing 0.9% (3.2% ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in